Abstract
Given the fact that proton pump inhibitors are known to be interfering with the amount of drugs available for absorption (139) and low MPA exposure is associated with acute rejection risk (88), it is necessary to evaluate the impact of pantoprazole as a proton pump inhibitor on the pharmacokinetics of MPA after intake with mycophenolate mofetil and EC-MPS in renal transplant patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer Fachmedien Wiesbaden GmbH
About this chapter
Cite this chapter
Rissling, O. (2017). Research Objectives. In: Interaction of Mycophenolic Acid and Pantoprazole. Springer Spektrum, Wiesbaden. https://doi.org/10.1007/978-3-658-19889-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-658-19889-3_2
Published:
Publisher Name: Springer Spektrum, Wiesbaden
Print ISBN: 978-3-658-19888-6
Online ISBN: 978-3-658-19889-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)